Contraception without bleeding – Existing options

Contraception without bleeding – Existing options

B. Pinter

Dept. of Ob/Gyn, University Medical Center, Ljubljana,

Slovenia

Introduction

Extended cycles, using oral contraceptives, have been used to

treat endometriosis and other menstrual disorders (menorrhagia, dysmenorrhea) or

to treat conditions that are known to be exacerbated cyclically (migraine,

epilepsy, irritable bowel syndrome and psychiatric symptoms). In addition,

extended cycles decrease blood loss during withdrawal bleedings and may provide

more effective protection from pregnancy.

Existing options

A variety of different extended cycle regimens are existing in

oral contraceptive use (Cochrane Database of Systematic Reviews): 42/7 regimen

(49-day cycle: 6 weeks of continuous use, 1 pill-free week), 63/7 regimen

(70-day cycle: 9 weeks of continuous use, 1 pill-free week), 84/7 regimen

(91-day cycle: 12 weeks of continuous use, 1 pill-free week), 161/7 regimen

(168-day cycle: 23 weeks of continuous use, 1 pill-free week) or 329/7 regimen

(336-day cycle: 47 weeks of continuous use, 1 pill-free week). Monophasic pill

containing 30 mcg or 20 mcg of etinilestradiol are prescribed (the first birth

control pill FDA approved for extended cycling was Seasonale), with comparable

efficacy.

Study on extended use of transdermal contraceptive patch (12

weeks of continuous use, 1 patch-free week) has shown that this regimen may be

useful alternative regimen, too. Extended regimens were studied also for

contraceptive vaginal ring (NuvaRing). Comparison among 28-day cycle, 49-day

cycle, 91-day cycle and 364-day cycle (51 weeks of continuous use, 1 ring-free

week) showed comparable efficacy of regimens, but spotting days increased with

postponement of the withdrawal bleeding. In addition, the studies on extended

use of progesterone-releasing vaginal ring in nursing women are going on.

Contraception without bleeding can be achieved also with depo

injectables, implants and levonorgestrel releasing IUS, if breakthrough bleeding

and spotting do not exceed amenorrhoic effects.

Conclusions

Contraception without bleeding in extended contraceptive use is

a reasonable approach in hormonal contraception.

Scroll to Top